Iloprost Power 15 in Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

iloprost (5 µg)

Single dose of iloprost 5 µg using I-neb(R) Adaptive Aerosol Delivery (AAD(R)) System power setting 15 disc

DRUG

placebo

Single dose of matching placebo using I-neb(R) Adaptive Aerosol Delivery (AAD(R)) System power setting 15 disc

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00709956 - Iloprost Power 15 in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter